Protopic® (tacrolimus) Ointment 0.03%Ointment 0.1% FOR DERMATOLOGIC USE ONLYNOT FOR OPHTHALMIC USE
Effectiveness of tacrolimus ointment on facial lesions refractory to topical corticosteroid in patients with atopic dermatitis receiving dupilumab - Uchida - 2022 - Journal of Cutaneous Immunology and Allergy - Wiley Online Library